STOP GAMES Act of 2026

The STOP GAMES Act of 2026 aims to speed up the approval of new drugs by restricting the ability to file petitions intended to delay the process. It empowers the Food and Drug Administration to deny petitions that lack valid scientific grounds or are submitted with the primary purpose of causing delays, such as those filed too late, too frequently, or without supporting data. Additionally, the bill requires courts to dismiss lawsuits challenging drug approvals if the parties have not first exhausted administrative remedies by filing a petition. The legislation also mandates that the FDA report to Congress on the number of petitions filed, the resources they consume, and the specific delays they cause to drug approvals.